Clinical Trials · NCT07777575

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

Phase
Phase 4
Recruitment status
Recruiting
Sponsor
Technical University of Munich
Enrollment
150
Start date
Sep 2026
Locations
1 site, Germany
Primary endpoint
Change in contractile thigh muscle volume (mL), as assessed by magnetic resonance imaging (MRI)
View Tirzepatide compound reference